Work

Dendritic Cell-based Full-length Survivin Vaccine in Treatment of Experimental Tumors

Year: 2007

Type: article

Source: Journal of Immunotherapy

DOI: 10.1097/01.cji.0000211329.83890.ba

Authors: Srinivas Nagaraj, Vladimir Pisarev, Leo Kinarsky, Simon Sherman, Carlos Muro-Cacho, Dario C. Altieri, Dmitry I. Gabrilovich

Institutions: University of South Florida, Moffitt Cancer Center, University of Nebraska Medical Center, University of Miami, University of Massachusetts Chan Medical School

Language: English

Topic: Immunotherapy and Immune Responses

Subfield: Immunology

Field: Immunology and Microbiology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

Funders: National Institutes of Health, National Heart, Lung, and Blood Institute, National Cancer Institute

Awards: G1173462143, Control of Apoptosis in Cancer by Survivin, G2297662783, Molecular targeting of the survivin pathway in cancer, IL3,IL5, and GM-CSF Signaling and Asthma, G7047910

OpenAlex ID: W2060076339

FWCI: 1.536

Cites: 46

Cited by: 48

Related to: 10